Company Filing History:

4 out of 37

Idec Pharmaceuticals Corporation

patents

1 out of 3

Idec Pharmaceutical Corporation

4. 2 out of 832,880

Other

patents

Years Active: 1993-2004

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6733763 - Induction of cytotoxic T-lymphocyte responses (2004-05-11),

2. 6312731 - Rapid release encapsulated bioactive agents for inducing or potentiating an immune response and methods of using thereof (2001-11-06),

3. 6270769 - Induction of cytotoxic T-lymphocyte responses (2001-08-07),

4. 6197311 - Induction of cytotoxic T-lymphocyte responses (2001-03-06),

5. 5709860 - Induction of cytotoxic T-lymphocyte responses (1998-01-20),

6. 5695770 - Induction of cytotoxic T-lymphocyte responses (1997-12-09),

7. 5585103 - Induction of cytotoxic T-lymphocyte responses (1996-12-17),

8. 5270202 - Anti-idiotypic antibodies to human melanoma-associated proteoglycan (1993-12-14),

Title: Syamal Raychaudhuri - Innovator from San Diego

Introduction: Syamal Raychaudhuri is a renowned inventor based in San Diego, CA, known for his groundbreaking contributions to various fields.

Latest Patents: Syamal Raychaudhuri holds several patents in the areas of biotechnology, renewable energy, and medical devices, showcasing his diverse range of expertise.

Career Highlights: With a career spanning over two decades, Syamal Raychaudhuri has worked with leading research institutions and companies, consistently pushing the boundaries of innovation.

Collaborations: Throughout his career, Syamal Raychaudhuri has collaborated with top scientists, engineers, and entrepreneurs, fostering a culture of creativity and excellence in his projects.

Conclusion: Syamal Raychaudhuri's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and researchers worldwide.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com